Bank Julius Baer & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681K | Sell |
1,300
-1,637
| -56% | -$858K | ﹤0.01% | 355 |
|
|
2025
Q1 | $2.08M | Sell |
2,937
-115,343
| -98% | -$81.8M | 0.01% | 284 |
|
|
2024
Q4 | $90.5M | Buy |
118,280
+10,291
| +10% | +$7.87M | 0.28% | 86 |
|
|
2024
Q3 | $129M | Sell |
107,989
-4,959
| -4% | -$5.93M | 0.43% | 57 |
|
|
2024
Q2 | $128M | Sell |
112,948
-4,933
| -4% | -$5.61M | 0.49% | 52 |
|
|
2024
Q1 | $113M | Buy |
117,881
+26,610
| +29% | +$25.6M | 0.43% | 65 |
|
|
2023
Q4 | $100M | Buy |
91,271
+7,170
| +9% | +$7.86M | 0.42% | 70 |
|
|
2023
Q3 | $69.2M | Buy |
84,101
+8,947
| +12% | +$7.36M | 0.4% | 66 |
|
|
2023
Q2 | $54M | Sell |
75,154
-6,280
| -8% | -$4.51M | 0.32% | 72 |
|
|
2023
Q1 | $66.9M | Buy |
81,434
+7,246
| +10% | +$5.95M | 0.43% | 62 |
|
|
2022
Q4 | $53.5M | Sell |
74,188
-27,470
| -27% | -$19.8M | 0.37% | 67 |
|
|
2022
Q3 | $70M | Buy |
101,658
+413
| +0.4% | +$285K | 0.53% | 47 |
|
|
2022
Q2 | $59.8M | Buy |
101,245
+99,535
| +5,821% | +$58.8M | 0.42% | 58 |
|
|
2022
Q1 | $1.19M | Buy |
1,710
+1,183
| +224% | +$826K | 0.01% | 266 |
|
|
2021
Q4 | $333K | Sell |
527
-8
| -1% | -$5.06K | ﹤0.01% | 470 |
|
|
2021
Q3 | $324K | Sell |
535
-292
| -35% | -$177K | ﹤0.01% | 492 |
|
|
2021
Q2 | $462K | Buy |
827
+77
| +10% | +$43K | ﹤0.01% | 460 |
|
|
2021
Q1 | $355K | Sell |
750
-111
| -13% | -$52.5K | ﹤0.01% | 495 |
|
|
2020
Q4 | $416K | Buy |
861
+148
| +21% | +$71.5K | ﹤0.01% | 483 |
|
|
2020
Q3 | $399K | Sell |
713
-965
| -58% | -$540K | ﹤0.01% | 414 |
|
|
2020
Q2 | $1.05M | Buy |
+1,678
| New | +$1.05M | 0.01% | 266 |
|